Formation Bio Expands Leadership Team with Industry Veterans

September 23, 2025
Formation Bio has announced the addition of four seasoned executives to its leadership team to enhance its AI-driven drug development efforts.

Formation Bio has announced the appointment of four experienced executives to its leadership team to bolster its AI-driven drug development initiatives, announced in a press release. The new appointees include Louis Brenner, MD, as Chief Medical Officer; Daniel Neil, PhD, as Chief Technology Officer; and Frank D'Amelio and Dashyant Dhanak, PhD, as Senior Advisors.

Louis Brenner, MD, brings over 20 years of experience in biotech and pharma, having previously served as President and CEO of Hopewell Therapeutics. Daniel Neil, PhD, joins as Chief Technology Officer with a strong background in machine learning and AI, having led AI/ML strategies at Tessera Therapeutics and BenevolentAI.

Frank D'Amelio, with nearly 15 years as Chief Financial Officer at Pfizer, joins as a Strategic Advisor. Dashyant Dhanak, PhD, who has held senior roles at Incyte and BenevolentAI, will also serve as a Strategic Advisor. These appointments aim to strengthen Formation Bio's capabilities in clinical, technological, financial, and scientific domains as it scales its AI-native pharma model.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/25
RamSoft Integrates Koios AI for Enhanced Cancer Diagnosis
09/25
Infinitus Systems Introduces MCP Server for Healthcare AI Interoperability
09/25
Avant Technologies Enters Longevity Biotech with Klothonova Joint Venture
09/25
Thyme Care Secures $97M Series D to Expand AI-Driven Oncology Solutions
09/25
Digital Pathology Market to Reach $3.86 Billion by 2033

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential

This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.

Read more

You May Also Like